UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes

Leukemia, 2008-02, Vol.22 (2), p.313-322

2008

Volltextzugriff (PDF)

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment

Leukemia, 2016-03, Vol.30 (3), p.562-569

2016

Volltextzugriff (PDF)

Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)

Leukemia, 2016-07, Vol.30 (7), p.1580-1582

2016

Volltextzugriff (PDF)

SRSF2 and U2AF1 mutations in primary myelofibrosis are associated with JAK2 and MPL but not calreticulin mutation and may independently reoccur after allogeneic stem cell transplantation

Leukemia, 2015-01, Vol.29 (1), p.253-255

2015

Volltextzugriff (PDF)

Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia

Leukemia, 2007-12, Vol.21 (12), p.2420-2427

2007

Volltextzugriff (PDF)

Selection for Evi1 activation in myelomonocytic leukemia induced by hyperactive signaling through wild-type NRas

Oncogene, 2013-06, Vol.32 (25), p.3028-3038

2013

Volltextzugriff (PDF)

Lentiviral vectors for induction of self-differentiation and conditional ablation of dendritic cells

Gene therapy, 2011-08, Vol.18 (8), p.750-764

2011

Volltextzugriff (PDF)

Systemic mastocytosis (SM) with associated BCR-ABL-positive myelogenous leukaemia (SM-AHNMD): evidence that mast cells do not belong to the leukaemic clone

Leukemia, 2011-06, Vol.25 (6), p.1050-1053

2011

Volltextzugriff (PDF)

Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia - prospective long-term results from a randomized-controlled trial

Leukemia, 2003-12, Vol.17 (12), p.2444-2453

2003

Volltextzugriff (PDF)

P-198 SPARC and TNF-α contribute significantly to erythroid failure in MDS with 5q deletion and influence considerably the efficacy of lenalidomide

Leukemia research, 2013-05, Vol.37, p.S113-S113

2013

Volltextzugriff (PDF)

P-239 Telomere length of granulocytes significantly increases during the first six months of lenalidomide treatment in patients with isolated 5q- syndrome

Leukemia research, 2013-05, Vol.37, p.S130-S131

2013

Volltextzugriff (PDF)

269 Mechanisms of action of lenalidomide on erythroblastic islands in patients with low- or intermediate-1-risk MDS with del(5q) chromosome abnormality

Leukemia research, 2011, Vol.35, p.S106-S106

2011

Volltextzugriff (PDF)

Fibrotic progression in Polycythemia vera is associated with early concomitant driver-mutations besides JAK2

Leukemia, 2018-02, Vol.32 (2), p.556-558

2018

Volltextzugriff (PDF)

Diagnosis and quantification of bone marrow fibrosis are significantly biased by the pre-staining processing of bone marrow biopsies

Histopathology, 2006-01, Vol.48 (2), p.133-148

2006

Volltextzugriff (PDF)

Impaired formation of erythroblastic islands is associated with erythroid failure and poor prognosis in a significant proportion of patients with myelodysplastic syndromes

Haematologica (Roma), 2016-05, Vol.101 (5), p.e177

2016

Volltextzugriff (PDF)

RNA-binding protein (RBFOX1) inherited polymorphism rs8051518 is not associated with splice factor mutations in myelodysplastic syndromes and myeloproliferative neoplasms

Annals of hematology, 2019-05, Vol.98 (5), p.1297-1299

2019

Volltextzugriff (PDF)

Classification and Staging of Ph-negative Myeloproliferative Disorders by Histopathology from Bone Marrow Biopsies

Leukemia & lymphoma, 1996-01, Vol.22 (S1), p.15-29

1996

Volltextzugriff (PDF)

Evolution of chronic myelomonocytic leukemia to myeloproliferative neoplasm

Annals of hematology, 2016-08, Vol.95 (8), p.1377-1380

2016

Volltextzugriff (PDF)

Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomide

Leukemia, 2012-04, Vol.26 (4), p.855-858

2012

Volltextzugriff (PDF)

Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomide

Leukemia, 2012-02, Vol.26 (2), p.356-358

2012

Volltextzugriff (PDF)

De novo CSF3R mutation associated with transformation of myeloproliferative neoplasm to atypical CML

Annals of hematology, 2015-07, Vol.94 (7), p.1255-1256

2015

Volltextzugriff (PDF)

Evaluating the volume ratio of bone marrow affected by fibrosis: A parameter crucial for the prognostic significance of marrow fibrosis in chronic myeloid leukemia

Human pathology, 2003-04, Vol.34 (4), p.391-401

2003

Volltextzugriff (PDF)

The histopathology of chronic myeloproliferative diseases

Baillière's clinical haematology, 1998-12, Vol.11 (4), p.721-749

1998

Volltextzugriff (PDF)

Bone marrow fibrosis in primary myelofibrosis in relation to myelodysplasia- and age-related mutations of hematopoietic cells

Der Pathologe, 2020-12, Vol.41 (Suppl 2), p.124-128

2020

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Deutsch
(51)
Englisch
(39)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(33)
Science & Technology
(33)
Humans
(27)
Hematology
(23)
Oncology
(20)
Female
(15)
Male
(14)
Aged
(13)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Bone Marrow
(11)
Hematologic And Hematopoietic Diseases
(11)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(11)
Bone Marrow - Pathology
(10)
Middle Aged
(10)
Adult
(9)
Genetic Aspects
(9)
Leukemia
(9)
Medicine
(9)
Medicine & Public Health
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)

Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment

Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)

SRSF2 and U2AF1 mutations in primary myelofibrosis are associated with JAK2 and MPL but not calreticulin mutation and may independently reoccur after allogeneic stem cell transplantation

Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia

Selection for Evi1 activation in myelomonocytic leukemia induced by hyperactive signaling through wild-type NRas

Lentiviral vectors for induction of self-differentiation and conditional ablation of dendritic cells

Systemic mastocytosis (SM) with associated BCR-ABL-positive myelogenous leukaemia (SM-AHNMD): evidence that mast cells do not belong to the leukaemic clone

Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia - prospective long-term results from a randomized-controlled trial

P-198 SPARC and TNF-α contribute significantly to erythroid failure in MDS with 5q deletion and influence considerably the efficacy of lenalidomide

P-239 Telomere length of granulocytes significantly increases during the first six months of lenalidomide treatment in patients with isolated 5q- syndrome

269 Mechanisms of action of lenalidomide on erythroblastic islands in patients with low- or intermediate-1-risk MDS with del(5q) chromosome abnormality

Fibrotic progression in Polycythemia vera is associated with early concomitant driver-mutations besides JAK2

Diagnosis and quantification of bone marrow fibrosis are significantly biased by the pre-staining processing of bone marrow biopsies

Impaired formation of erythroblastic islands is associated with erythroid failure and poor prognosis in a significant proportion of patients with myelodysplastic syndromes

RNA-binding protein (RBFOX1) inherited polymorphism rs8051518 is not associated with splice factor mutations in myelodysplastic syndromes and myeloproliferative neoplasms

Classification and Staging of Ph-negative Myeloproliferative Disorders by Histopathology from Bone Marrow Biopsies

Evolution of chronic myelomonocytic leukemia to myeloproliferative neoplasm

Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomide

Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomide

De novo CSF3R mutation associated with transformation of myeloproliferative neoplasm to atypical CML

Evaluating the volume ratio of bone marrow affected by fibrosis: A parameter crucial for the prognostic significance of marrow fibrosis in chronic myeloid leukemia

The histopathology of chronic myeloproliferative diseases

Bone marrow fibrosis in primary myelofibrosis in relation to myelodysplasia- and age-related mutations of hematopoietic cells

Suchergebnisse filtern